Skip to main content
Clinical Trials/NCT04822259
NCT04822259
Withdrawn
Not Applicable

A Prospective Multi-Centre Study in Patients Undergoing Total Knee Replacement With JOURNEY II BCS and CR Total Knee System

Smith & Nephew, Inc.5 sites in 3 countriesAugust 28, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Arthroplasty
Sponsor
Smith & Nephew, Inc.
Locations
5
Primary Endpoint
Oxford Knee Score (OKS) at 2 years
Status
Withdrawn
Last Updated
3 years ago

Overview

Brief Summary

Background:

The JOURNEY II BCS Total Knee System (JOURNEY II Bi-cruciate Stabilized Total Knee System) consists of femoral component made from oxidized zirconium (OXINIUM)

The JOURNEY II CR Total Knee System (JOURNEY II Cruciate Retaining Total Knee System ) consists of femoral component made from oxidized zirconium (OXINIUM)

Purpose:

Post-market evidence generation for JOURNEY II BCS and JOURNEY II CR Total Knee System

Objectives:

  1. Evaluate the performance of JOURNEY II TKA in Asia-Pacific (APAC) patient populations
  2. Establish the equivalent performance between JOURNEY II BCS and JOURNEY II CR to support adoption of JOURNEY II CR

Research participants / locations:

A total of at least 176 knees' information will be collected in up to 10 sites. There will be at least eighty-eight (88) knees for JOURNEY II CR TKA group and at least 88 knees for JOURNEY II BCS TKA group.

Registry
clinicaltrials.gov
Start Date
August 28, 2022
End Date
December 31, 2025
Last Updated
3 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Subjects with degenerative osteoarthritis.
  • Subject is planning to have bilateral Total Knee Arthroplasty (TKA) using JOURNEY II BCS \& CR or have unilateral TKA using JOURNEY II BCS or JOURNEY II CR.\*
  • Subject is able and willing to provide voluntary consent to study participation.
  • Subject is 18-80 years old (inclusive).
  • \[\* Bilateral cases can be simultaneous bilateral or staged bilateral (which an interval of 6-8 weeks apart between both knees)\]

Exclusion Criteria

  • Subjects with rheumatoid arthritis/inflammatory arthritis, posttraumatic arthritis.
  • Previous surgeries including High Tibial Osteotomy (HTO), Unicondylar Knee Arthroplasty (UKA) or Total Knee Arthroplasty (TKA) on the subject knee.
  • Subject is pregnant or breast feeding or those at a child-bearing age planning to become pregnant during the follow up.
  • Subject does not meet the indication or is contraindicated for JOURNEY II BCS \& JOURNEY II CR's Instructions For Use (IFU).

Outcomes

Primary Outcomes

Oxford Knee Score (OKS) at 2 years

Time Frame: 2 years

The Oxford Knee Score (OKS) is a Patient Reported Outcome (PRO) questionnaire that was developed to specifically assess the patient's perspective of outcome following Total Knee Arthroplasty (TKA). The OKS is a patient self-completion PRO containing 12 equally weighted questions on activities of daily living. The OKS has been developed and validated specifically to assess perceived function and pain answered on a Likert scale after TKA. Responses to each question ranges from 0-4 with a range of a possible overall score from 0-48. A score of 0 is the worst possible outcome while a score of 48 is the best possible outcome.

Secondary Outcomes

  • Timed Up and Go Test (TUG)(Pre-Operative, Immediate Post -op to 6 weeks, 6 months, 1 year)
  • Oxford Knee Score (OKS)(Pre-Operative, 6 months, 1 year, 3 years)
  • Knee Society Score (KSS)(Pre-Operative, 6 months, 1 year, 2 years, 3 years)
  • Patient Expectation(Pre-Operative)
  • Radiographic Assessment(Pre-Operative, 6 months, 1 year, 2 years, 3 years)
  • Forgotten Joint Score (FJS)(6 months, 1 year , 2 years, 3 years)
  • Patient Satisfaction(6 months, 1 year, 2 years, 3 years)
  • Star Excursion Balance Test (SEBT)(Pre-Operative, Immediate Post -op to 6 weeks, 6 months, 1 year)

Study Sites (5)

Loading locations...

Similar Trials